Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 18.0B | 17.6B | 20.8B | 21.4B |
Cost of revenue | 12.0B | 11.6B | 14.8B | 14.6B |
Gross profit | 5.9B | 6.0B | 5.9B | 6.8B |
Operating expense | ||||
Research & development | 79.3M | 60.8M | 82.0M | 68.7M |
Selling general and admin | 3.6B | 3.6B | 3.5B | 3.9B |
Other operating expenses | — | — | — | — |
Operating income | 2.2B | 2.3B | 2.4B | 2.9B |
Non operating interest income | ||||
Income | 85.3M | 60.7M | 110.2M | 89.6M |
Expense | 149.6M | 121.1M | 111.6M | 119.3M |
Other income expense | — | — | — | — |
Pretax income | 1.5B | 1.5B | 1.4B | 3.0B |
Tax provision | 660.5M | 386.8M | 368.0M | 754.3M |
Net income | 840.0M | 1.1B | 992.1M | 2.2B |
Basic EPS | 0.1 | 0.4 | — | 1.2 |
Diluted EPS | 0.1 | 0.4 | — | 1.1 |
Basic average shares | 1.1B | 1.0B | — | 1.0B |
Diluted average shares | 1.1B | 1.0B | — | 1.1B |
EBITDA | 5.3B | 5.4B | 5.5B | 7.1B |
Net income from continuing op. | 1.5B | 1.5B | 1.4B | 3.0B |
Minority interests | -724.4M | -642.4M | -392.3M | -925.6M |
Preferred stock dividends | 0 | 0 | 0 | 0 |